Global Live Attenuated Rotavirus Vaccine Market Research Report 2025(Status and Outlook)

March 2025 | 153 pages | ID: G14970FC7C80EN
Bosson Research

Abstracts

Report Overview

Rotavirus spreads easily among infants and young children. The virus can cause severe watery diarrhea, vomiting, fever, and abdominal pain. Children who get rotavirus disease can become dehydrated and may need to be hospitalized. Live attenuated rotavirus vaccine is a vaccine created by reducing the virulence of a pathogen, but still keeping it viable.

This report provides a deep insight into the global Live Attenuated Rotavirus Vaccine market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Live Attenuated Rotavirus Vaccine Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Live Attenuated Rotavirus Vaccine market in any manner.

Global Live Attenuated Rotavirus Vaccine Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Merck Sharp & Dohme

GSK

Bharat Biotech

Lanzhou Biological Products Research Institute

Market Segmentation (by Type)

Monovalent Vaccines

Combination Vaccines

Market Segmentation (by Application)

Hospitals and Clinics

Vaccination Sites

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Live Attenuated Rotavirus Vaccine Market
• Overview of the regional outlook of the Live Attenuated Rotavirus Vaccine Market:

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Live Attenuated Rotavirus Vaccine Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.

Contents

1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of Live Attenuated Rotavirus Vaccine
1.2 Key Market Segments
  1.2.1 Live Attenuated Rotavirus Vaccine Segment by Type
  1.2.2 Live Attenuated Rotavirus Vaccine Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 LIVE ATTENUATED ROTAVIRUS VACCINE MARKET OVERVIEW

2.1 Global Market Overview
  2.1.1 Global Live Attenuated Rotavirus Vaccine Market Size (M USD) Estimates and Forecasts (2020-2033)
  2.1.2 Global Live Attenuated Rotavirus Vaccine Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 LIVE ATTENUATED ROTAVIRUS VACCINE MARKET COMPETITIVE LANDSCAPE

3.1 Company Assessment Quadrant
3.2 Global Live Attenuated Rotavirus Vaccine Product Life Cycle
3.3 Global Live Attenuated Rotavirus Vaccine Sales by Manufacturers (2020-2025)
3.4 Global Live Attenuated Rotavirus Vaccine Revenue Market Share by Manufacturers (2020-2025)
3.5 Live Attenuated Rotavirus Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Live Attenuated Rotavirus Vaccine Average Price by Manufacturers (2020-2025)
3.7 Manufacturers Live Attenuated Rotavirus Vaccine Manufacturing Sites, Area Served, Product Type
3.8 Live Attenuated Rotavirus Vaccine Market Competitive Situation and Trends
  3.8.1 Live Attenuated Rotavirus Vaccine Market Concentration Rate
  3.8.2 Global 5 and 10 Largest Live Attenuated Rotavirus Vaccine Players Market Share by Revenue
  3.8.3 Mergers & Acquisitions, Expansion

4 LIVE ATTENUATED ROTAVIRUS VACCINE INDUSTRY CHAIN ANALYSIS

4.1 Live Attenuated Rotavirus Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF LIVE ATTENUATED ROTAVIRUS VACCINE MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
  5.4.1 New Product Developments
  5.4.2 Mergers & Acquisitions
  5.4.3 Expansions
  5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
  5.5.1 Industry Policies Analysis
  5.5.2 Economic Environment Analysis
  5.5.3 Social Environment Analysis
  5.5.4 Technological Environment Analysis
5.6 Global Live Attenuated Rotavirus Vaccine Market Porter's Five Forces Analysis
  5.6.1 Global Trade Frictions
  5.6.2 Global Trade Frictions and Their Impacts to Live Attenuated Rotavirus Vaccine Market
5.7 ESG Ratings of Leading Companies

6 LIVE ATTENUATED ROTAVIRUS VACCINE MARKET SEGMENTATION BY TYPE

6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Live Attenuated Rotavirus Vaccine Sales Market Share by Type (2020-2025)
6.3 Global Live Attenuated Rotavirus Vaccine Market Size Market Share by Type (2020-2025)
6.4 Global Live Attenuated Rotavirus Vaccine Price by Type (2020-2025)

7 LIVE ATTENUATED ROTAVIRUS VACCINE MARKET SEGMENTATION BY APPLICATION

7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Live Attenuated Rotavirus Vaccine Market Sales by Application (2020-2025)
7.3 Global Live Attenuated Rotavirus Vaccine Market Size (M USD) by Application (2020-2025)
7.4 Global Live Attenuated Rotavirus Vaccine Sales Growth Rate by Application (2020-2025)

8 LIVE ATTENUATED ROTAVIRUS VACCINE MARKET SALES BY REGION

8.1 Global Live Attenuated Rotavirus Vaccine Sales by Region
  8.1.1 Global Live Attenuated Rotavirus Vaccine Sales by Region
  8.1.2 Global Live Attenuated Rotavirus Vaccine Sales Market Share by Region
8.2 Global Live Attenuated Rotavirus Vaccine Market Size by Region
  8.2.1 Global Live Attenuated Rotavirus Vaccine Market Size by Region
  8.2.2 Global Live Attenuated Rotavirus Vaccine Market Size Market Share by Region
8.3 North America
  8.3.1 North America Live Attenuated Rotavirus Vaccine Sales by Country
  8.3.2 North America Live Attenuated Rotavirus Vaccine Market Size by Country
  8.3.3 U.S. Market Overview
  8.3.4 Canada Market Overview
  8.3.5 Mexico Market Overview
8.4 Europe
  8.4.1 Europe Live Attenuated Rotavirus Vaccine Sales by Country
  8.4.2 Europe Live Attenuated Rotavirus Vaccine Market Size by Country
  8.4.3 Germany Market Overview
  8.4.4 France Market Overview
  8.4.5 U.K. Market Overview
  8.4.6 Italy Market Overview
  8.4.7 Spain Market Overview
8.5 Asia Pacific
  8.5.1 Asia Pacific Live Attenuated Rotavirus Vaccine Sales by Region
  8.5.2 Asia Pacific Live Attenuated Rotavirus Vaccine Market Size by Region
  8.5.3 China Market Overview
  8.5.4 Japan Market Overview
  8.5.5 South Korea Market Overview
  8.5.6 India Market Overview
  8.5.7 Southeast Asia Market Overview
8.6 South America
  8.6.1 South America Live Attenuated Rotavirus Vaccine Sales by Country
  8.6.2 South America Live Attenuated Rotavirus Vaccine Market Size by Country
  8.6.3 Brazil Market Overview
  8.6.4 Argentina Market Overview
  8.6.5 Columbia Market Overview
8.7 Middle East and Africa
  8.7.1 Middle East and Africa Live Attenuated Rotavirus Vaccine Sales by Region
  8.7.2 Middle East and Africa Live Attenuated Rotavirus Vaccine Market Size by Region
  8.7.3 Saudi Arabia Market Overview
  8.7.4 UAE Market Overview
  8.7.5 Egypt Market Overview
  8.7.6 Nigeria Market Overview
  8.7.7 South Africa Market Overview

9 LIVE ATTENUATED ROTAVIRUS VACCINE MARKET PRODUCTION BY REGION

9.1 Global Production of Live Attenuated Rotavirus Vaccine by Region(2020-2025)
9.2 Global Live Attenuated Rotavirus Vaccine Revenue Market Share by Region (2020-2025)
9.3 Global Live Attenuated Rotavirus Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Live Attenuated Rotavirus Vaccine Production
  9.4.1 North America Live Attenuated Rotavirus Vaccine Production Growth Rate (2020-2025)
  9.4.2 North America Live Attenuated Rotavirus Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Live Attenuated Rotavirus Vaccine Production
  9.5.1 Europe Live Attenuated Rotavirus Vaccine Production Growth Rate (2020-2025)
  9.5.2 Europe Live Attenuated Rotavirus Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Live Attenuated Rotavirus Vaccine Production (2020-2025)
  9.6.1 Japan Live Attenuated Rotavirus Vaccine Production Growth Rate (2020-2025)
  9.6.2 Japan Live Attenuated Rotavirus Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Live Attenuated Rotavirus Vaccine Production (2020-2025)
  9.7.1 China Live Attenuated Rotavirus Vaccine Production Growth Rate (2020-2025)
  9.7.2 China Live Attenuated Rotavirus Vaccine Production, Revenue, Price and Gross Margin (2020-2025)

10 KEY COMPANIES PROFILE

10.1 Merck Sharp and Dohme
  10.1.1 Merck Sharp and Dohme Basic Information
  10.1.2 Merck Sharp and Dohme Live Attenuated Rotavirus Vaccine Product Overview
  10.1.3 Merck Sharp and Dohme Live Attenuated Rotavirus Vaccine Product Market Performance
  10.1.4 Merck Sharp and Dohme Business Overview
  10.1.5 Merck Sharp and Dohme SWOT Analysis
  10.1.6 Merck Sharp and Dohme Recent Developments
10.2 GSK
  10.2.1 GSK Basic Information
  10.2.2 GSK Live Attenuated Rotavirus Vaccine Product Overview
  10.2.3 GSK Live Attenuated Rotavirus Vaccine Product Market Performance
  10.2.4 GSK Business Overview
  10.2.5 GSK SWOT Analysis
  10.2.6 GSK Recent Developments
10.3 Bharat Biotech
  10.3.1 Bharat Biotech Basic Information
  10.3.2 Bharat Biotech Live Attenuated Rotavirus Vaccine Product Overview
  10.3.3 Bharat Biotech Live Attenuated Rotavirus Vaccine Product Market Performance
  10.3.4 Bharat Biotech Business Overview
  10.3.5 Bharat Biotech SWOT Analysis
  10.3.6 Bharat Biotech Recent Developments
10.4 Lanzhou Biological Products Research Institute
  10.4.1 Lanzhou Biological Products Research Institute Basic Information
  10.4.2 Lanzhou Biological Products Research Institute Live Attenuated Rotavirus Vaccine Product Overview
  10.4.3 Lanzhou Biological Products Research Institute Live Attenuated Rotavirus Vaccine Product Market Performance
  10.4.4 Lanzhou Biological Products Research Institute Business Overview
  10.4.5 Lanzhou Biological Products Research Institute Recent Developments

11 LIVE ATTENUATED ROTAVIRUS VACCINE MARKET FORECAST BY REGION

11.1 Global Live Attenuated Rotavirus Vaccine Market Size Forecast
11.2 Global Live Attenuated Rotavirus Vaccine Market Forecast by Region
  11.2.1 North America Market Size Forecast by Country
  11.2.2 Europe Live Attenuated Rotavirus Vaccine Market Size Forecast by Country
  11.2.3 Asia Pacific Live Attenuated Rotavirus Vaccine Market Size Forecast by Region
  11.2.4 South America Live Attenuated Rotavirus Vaccine Market Size Forecast by Country
  11.2.5 Middle East and Africa Forecasted Sales of Live Attenuated Rotavirus Vaccine by Country

12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)

12.1 Global Live Attenuated Rotavirus Vaccine Market Forecast by Type (2026-2033)
  12.1.1 Global Forecasted Sales of Live Attenuated Rotavirus Vaccine by Type (2026-2033)
  12.1.2 Global Live Attenuated Rotavirus Vaccine Market Size Forecast by Type (2026-2033)
  12.1.3 Global Forecasted Price of Live Attenuated Rotavirus Vaccine by Type (2026-2033)
12.2 Global Live Attenuated Rotavirus Vaccine Market Forecast by Application (2026-2033)
  12.2.1 Global Live Attenuated Rotavirus Vaccine Sales (K Units) Forecast by Application
  12.2.2 Global Live Attenuated Rotavirus Vaccine Market Size (M USD) Forecast by Application (2026-2033)

13 CONCLUSION AND KEY FINDINGS
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Live Attenuated Rotavirus Vaccine Market Size Comparison by Region (M USD)
Table 5. Global Live Attenuated Rotavirus Vaccine Sales (K Units) by Manufacturers (2020-2025)
Table 6. Global Live Attenuated Rotavirus Vaccine Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Live Attenuated Rotavirus Vaccine Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Live Attenuated Rotavirus Vaccine Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Live Attenuated Rotavirus Vaccine as of 2024)
Table 10. Global Market Live Attenuated Rotavirus Vaccine Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 11. Manufacturers Live Attenuated Rotavirus Vaccine Manufacturing Sites and Area Served
Table 12. Manufacturers Live Attenuated Rotavirus Vaccine Product Type
Table 13. Global Live Attenuated Rotavirus Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Live Attenuated Rotavirus Vaccine Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. Global Live Attenuated Rotavirus Vaccine Sales by Type (K Units)
Table 25. Global Live Attenuated Rotavirus Vaccine Market Size by Type (M USD)
Table 26. Global Live Attenuated Rotavirus Vaccine Sales (K Units) by Type (2020-2025)
Table 27. Global Live Attenuated Rotavirus Vaccine Sales Market Share by Type (2020-2025)
Table 28. Global Live Attenuated Rotavirus Vaccine Market Size (M USD) by Type (2020-2025)
Table 29. Global Live Attenuated Rotavirus Vaccine Market Size Share by Type (2020-2025)
Table 30. Global Live Attenuated Rotavirus Vaccine Price (USD/Unit) by Type (2020-2025)
Table 31. Global Live Attenuated Rotavirus Vaccine Sales (K Units) by Application
Table 32. Global Live Attenuated Rotavirus Vaccine Market Size by Application
Table 33. Global Live Attenuated Rotavirus Vaccine Sales by Application (2020-2025) & (K Units)
Table 34. Global Live Attenuated Rotavirus Vaccine Sales Market Share by Application (2020-2025)
Table 35. Global Live Attenuated Rotavirus Vaccine Market Size by Application (2020-2025) & (M USD)
Table 36. Global Live Attenuated Rotavirus Vaccine Market Share by Application (2020-2025)
Table 37. Global Live Attenuated Rotavirus Vaccine Sales Growth Rate by Application (2020-2025)
Table 38. Global Live Attenuated Rotavirus Vaccine Sales by Region (2020-2025) & (K Units)
Table 39. Global Live Attenuated Rotavirus Vaccine Sales Market Share by Region (2020-2025)
Table 40. Global Live Attenuated Rotavirus Vaccine Market Size by Region (2020-2025) & (M USD)
Table 41. Global Live Attenuated Rotavirus Vaccine Market Size Market Share by Region (2020-2025)
Table 42. North America Live Attenuated Rotavirus Vaccine Sales by Country (2020-2025) & (K Units)
Table 43. North America Live Attenuated Rotavirus Vaccine Market Size by Country (2020-2025) & (M USD)
Table 44. Europe Live Attenuated Rotavirus Vaccine Sales by Country (2020-2025) & (K Units)
Table 45. Europe Live Attenuated Rotavirus Vaccine Market Size by Country (2020-2025) & (M USD)
Table 46. Asia Pacific Live Attenuated Rotavirus Vaccine Sales by Region (2020-2025) & (K Units)
Table 47. Asia Pacific Live Attenuated Rotavirus Vaccine Market Size by Region (2020-2025) & (M USD)
Table 48. South America Live Attenuated Rotavirus Vaccine Sales by Country (2020-2025) & (K Units)
Table 49. South America Live Attenuated Rotavirus Vaccine Market Size by Country (2020-2025) & (M USD)
Table 50. Middle East and Africa Live Attenuated Rotavirus Vaccine Sales by Region (2020-2025) & (K Units)
Table 51. Middle East and Africa Live Attenuated Rotavirus Vaccine Market Size by Region (2020-2025) & (M USD)
Table 52. Global Live Attenuated Rotavirus Vaccine Production (K Units) by Region(2020-2025)
Table 53. Global Live Attenuated Rotavirus Vaccine Revenue (US$ Million) by Region (2020-2025)
Table 54. Global Live Attenuated Rotavirus Vaccine Revenue Market Share by Region (2020-2025)
Table 55. Global Live Attenuated Rotavirus Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 56. North America Live Attenuated Rotavirus Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 57. Europe Live Attenuated Rotavirus Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. Japan Live Attenuated Rotavirus Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. China Live Attenuated Rotavirus Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Merck Sharp and Dohme Basic Information
Table 61. Merck Sharp and Dohme Live Attenuated Rotavirus Vaccine Product Overview
Table 62. Merck Sharp and Dohme Live Attenuated Rotavirus Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 63. Merck Sharp and Dohme Business Overview
Table 64. Merck Sharp and Dohme SWOT Analysis
Table 65. Merck Sharp and Dohme Recent Developments
Table 66. GSK Basic Information
Table 67. GSK Live Attenuated Rotavirus Vaccine Product Overview
Table 68. GSK Live Attenuated Rotavirus Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 69. GSK Business Overview
Table 70. GSK SWOT Analysis
Table 71. GSK Recent Developments
Table 72. Bharat Biotech Basic Information
Table 73. Bharat Biotech Live Attenuated Rotavirus Vaccine Product Overview
Table 74. Bharat Biotech Live Attenuated Rotavirus Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 75. Bharat Biotech Business Overview
Table 76. Bharat Biotech SWOT Analysis
Table 77. Bharat Biotech Recent Developments
Table 78. Lanzhou Biological Products Research Institute Basic Information
Table 79. Lanzhou Biological Products Research Institute Live Attenuated Rotavirus Vaccine Product Overview
Table 80. Lanzhou Biological Products Research Institute Live Attenuated Rotavirus Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 81. Lanzhou Biological Products Research Institute Business Overview
Table 82. Lanzhou Biological Products Research Institute Recent Developments
Table 83. Global Live Attenuated Rotavirus Vaccine Sales Forecast by Region (2026-2033) & (K Units)
Table 84. Global Live Attenuated Rotavirus Vaccine Market Size Forecast by Region (2026-2033) & (M USD)
Table 85. North America Live Attenuated Rotavirus Vaccine Sales Forecast by Country (2026-2033) & (K Units)
Table 86. North America Live Attenuated Rotavirus Vaccine Market Size Forecast by Country (2026-2033) & (M USD)
Table 87. Europe Live Attenuated Rotavirus Vaccine Sales Forecast by Country (2026-2033) & (K Units)
Table 88. Europe Live Attenuated Rotavirus Vaccine Market Size Forecast by Country (2026-2033) & (M USD)
Table 89. Asia Pacific Live Attenuated Rotavirus Vaccine Sales Forecast by Region (2026-2033) & (K Units)
Table 90. Asia Pacific Live Attenuated Rotavirus Vaccine Market Size Forecast by Region (2026-2033) & (M USD)
Table 91. South America Live Attenuated Rotavirus Vaccine Sales Forecast by Country (2026-2033) & (K Units)
Table 92. South America Live Attenuated Rotavirus Vaccine Market Size Forecast by Country (2026-2033) & (M USD)
Table 93. Middle East and Africa Live Attenuated Rotavirus Vaccine Sales Forecast by Country (2026-2033) & (Units)
Table 94. Middle East and Africa Live Attenuated Rotavirus Vaccine Market Size Forecast by Country (2026-2033) & (M USD)
Table 95. Global Live Attenuated Rotavirus Vaccine Sales Forecast by Type (2026-2033) & (K Units)
Table 96. Global Live Attenuated Rotavirus Vaccine Market Size Forecast by Type (2026-2033) & (M USD)
Table 97. Global Live Attenuated Rotavirus Vaccine Price Forecast by Type (2026-2033) & (USD/Unit)
Table 98. Global Live Attenuated Rotavirus Vaccine Sales (K Units) Forecast by Application (2026-2033)
Table 99. Global Live Attenuated Rotavirus Vaccine Market Size Forecast by Application (2026-2033) & (M USD)
List of Figures
Figure 1. Product Picture of Live Attenuated Rotavirus Vaccine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Live Attenuated Rotavirus Vaccine Market Size (M USD), 2024-2033
Figure 5. Global Live Attenuated Rotavirus Vaccine Market Size (M USD) (2020-2033)
Figure 6. Global Live Attenuated Rotavirus Vaccine Sales (K Units) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Live Attenuated Rotavirus Vaccine Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Live Attenuated Rotavirus Vaccine Product Life Cycle
Figure 13. Live Attenuated Rotavirus Vaccine Sales Share by Manufacturers in 2024
Figure 14. Global Live Attenuated Rotavirus Vaccine Revenue Share by Manufacturers in 2024
Figure 15. Live Attenuated Rotavirus Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Live Attenuated Rotavirus Vaccine Average Price (USD/Unit) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Live Attenuated Rotavirus Vaccine Revenue in 2024
Figure 18. Industry Chain Map of Live Attenuated Rotavirus Vaccine
Figure 19. Global Live Attenuated Rotavirus Vaccine Market PEST Analysis
Figure 20. Global Live Attenuated Rotavirus Vaccine Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Live Attenuated Rotavirus Vaccine Market Share by Type
Figure 27. Sales Market Share of Live Attenuated Rotavirus Vaccine by Type (2020-2025)
Figure 28. Sales Market Share of Live Attenuated Rotavirus Vaccine by Type in 2024
Figure 29. Market Size Share of Live Attenuated Rotavirus Vaccine by Type (2020-2025)
Figure 30. Market Size Share of Live Attenuated Rotavirus Vaccine by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Live Attenuated Rotavirus Vaccine Market Share by Application
Figure 33. Global Live Attenuated Rotavirus Vaccine Sales Market Share by Application (2020-2025)
Figure 34. Global Live Attenuated Rotavirus Vaccine Sales Market Share by Application in 2024
Figure 35. Global Live Attenuated Rotavirus Vaccine Market Share by Application (2020-2025)
Figure 36. Global Live Attenuated Rotavirus Vaccine Market Share by Application in 2024
Figure 37. Global Live Attenuated Rotavirus Vaccine Sales Growth Rate by Application (2020-2025)
Figure 38. Global Live Attenuated Rotavirus Vaccine Sales Market Share by Region (2020-2025)
Figure 39. Global Live Attenuated Rotavirus Vaccine Market Size Market Share by Region (2020-2025)
Figure 40. North America Live Attenuated Rotavirus Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Live Attenuated Rotavirus Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Live Attenuated Rotavirus Vaccine Sales Market Share by Country in 2024
Figure 43. North America Live Attenuated Rotavirus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Live Attenuated Rotavirus Vaccine Market Size Market Share by Country in 2024
Figure 45. U.S. Live Attenuated Rotavirus Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Live Attenuated Rotavirus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Live Attenuated Rotavirus Vaccine Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Live Attenuated Rotavirus Vaccine Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Live Attenuated Rotavirus Vaccine Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Live Attenuated Rotavirus Vaccine Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Live Attenuated Rotavirus Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Live Attenuated Rotavirus Vaccine Sales Market Share by Country in 2024
Figure 53. Europe Live Attenuated Rotavirus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Live Attenuated Rotavirus Vaccine Market Size Market Share by Country in 2024
Figure 55. Germany Live Attenuated Rotavirus Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Live Attenuated Rotavirus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Live Attenuated Rotavirus Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Live Attenuated Rotavirus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Live Attenuated Rotavirus Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Live Attenuated Rotavirus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Live Attenuated Rotavirus Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Live Attenuated Rotavirus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Live Attenuated Rotavirus Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Live Attenuated Rotavirus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Live Attenuated Rotavirus Vaccine Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Live Attenuated Rotavirus Vaccine Sales Market Share by Region in 2024
Figure 67. Asia Pacific Live Attenuated Rotavirus Vaccine Market Size Market Share by Region in 2024
Figure 68. China Live Attenuated Rotavirus Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Live Attenuated Rotavirus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Live Attenuated Rotavirus Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Live Attenuated Rotavirus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Live Attenuated Rotavirus Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Live Attenuated Rotavirus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Live Attenuated Rotavirus Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Live Attenuated Rotavirus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Live Attenuated Rotavirus Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Live Attenuated Rotavirus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Live Attenuated Rotavirus Vaccine Sales and Growth Rate (K Units)
Figure 79. South America Live Attenuated Rotavirus Vaccine Sales Market Share by Country in 2024
Figure 80. South America Live Attenuated Rotavirus Vaccine Market Size and Growth Rate (M USD)
Figure 81. South America Live Attenuated Rotavirus Vaccine Market Size Market Share by Country in 2024
Figure 82. Brazil Live Attenuated Rotavirus Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Live Attenuated Rotavirus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Live Attenuated Rotavirus Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Live Attenuated Rotavirus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Live Attenuated Rotavirus Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Live Attenuated Rotavirus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Live Attenuated Rotavirus Vaccine Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Live Attenuated Rotavirus Vaccine Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Live Attenuated Rotavirus Vaccine Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Live Attenuated Rotavirus Vaccine Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Live Attenuated Rotavirus Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Live Attenuated Rotavirus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Live Attenuated Rotavirus Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Live Attenuated Rotavirus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Live Attenuated Rotavirus Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Live Attenuated Rotavirus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Live Attenuated Rotavirus Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Live Attenuated Rotavirus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Live Attenuated Rotavirus Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Live Attenuated Rotavirus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Live Attenuated Rotavirus Vaccine Production Market Share by Region (2020-2025)
Figure 103. North America Live Attenuated Rotavirus Vaccine Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Live Attenuated Rotavirus Vaccine Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Live Attenuated Rotavirus Vaccine Production (K Units) Growth Rate (2020-2025)
Figure 106. China Live Attenuated Rotavirus Vaccine Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Live Attenuated Rotavirus Vaccine Sales Forecast by Volume (2020-2033) & (K Units)
Figure 108. Global Live Attenuated Rotavirus Vaccine Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Live Attenuated Rotavirus Vaccine Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Live Attenuated Rotavirus Vaccine Market Share Forecast by Type (2026-2033)
Figure 111. Global Live Attenuated Rotavirus Vaccine Sales Forecast by Application (2026-2033)
Figure 112. Global Live Attenuated Rotavirus Vaccine Market Share Forecast by Application (2026-2033)